5A2-SC8
Recommended because it shares a closely related research category or delivery context. Formulation and performance are product- and study-specific.
View product →
Ionizable lipid for LNP and nucleic-acid delivery research.
RCB-4-8 is a biodegradable ionizable lipid nanoparticle (LNP) engineered for efficient pulmonary mRNA delivery and in vivo genome editing, as detailed in the primary research article "Combinatorial design of nanoparticles for pulmonary mRNA delivery and genome editing" (Li et al., Nature Biotechnology 2023). Synthesized from a combinatorial library of 720 biodegradable lipids via a three-component reaction system, RCB-4-8 features an alkyne-containing lipid tail and tertiary amine headgroup, optimized through high-throughput screening for superior lung-targeting capabilities. Its unique molecular design incorporates hydrolyzable ester and carbonate groups, enabling rapid biodegradation (<30% lung retention at 48 h vs. >90% for conventional lipids) while maintaining high transfection efficiency. When formulated with DOTAP instead of DOPE, RCB-4-8 LNPs achieved 100-fold higher luciferase mRNA expression in murine lungs compared to FDA-approved MC3 LNPs and mediated 95% GFP knockout in vitro. In Ai9 reporter mice, intratracheal delivery of RCB-4-8 loaded with Cre mRNA edited 53% of total lung cells after three doses, while codelivery with Cas9 mRNA/sgRNA yielded 7.2% tdTomato<sup>+</sup> cells, rising to 17% when combined with AAV-sgRNAs. With an optimal particle size of 85.7 nm (PDI 0.11) and >87% mRNA encapsulation, RCB-4-8 supports repeat dosing and represents a transformative platform for inhalable gene therapies targeting congenital lung diseases like cystic fibrosis.
| CAS No. | Not available |
| Chemical Name | RCB-4-8 |
| Synonyms | RCB-4-8,RCB48, RCB 4 8,bis((Z)-12-(((non-2-yn-1-yloxy)carbonyl)oxy)octadec-9-en-1-yl) 3,3’-((2-(diethylamino)ethyl)azanediyl)dipropionate |
| SMILES | CCN(CC)CCN(CCC(OCCCCCCCC/C=C\CC(CCCCCC)OC(OCC#CCCCCCC)=O)=O)CCC(OCCCCCCCC/C=C\CC(CCCCCC)OC(OCC#CCCCCCC)=O)=O |
| Formula | C68H120N2O10 |
| M.Wt | 1,125.7 |
| Purity | ELSD-HPLC>95% |
| Storage | Pure form: −20 °C, 1 year; In solvent: −80 °C, 6 months; −20 °C, 1 month. Sealed and protected from light. |
| Shipping condition | Ships from Shanghai. Pure lipid is stable during ice-pack transport. |
| Publication | Li, B., Manan, R.S., Liang, S.-Q., et al. Combinatorial design of nanoparticles for pulmonary mRNA delivery and genome editing. Nat. Biotechnol. |
The product molecular weight is prefilled when available and remains editable. Confirm solvent compatibility and solubility before preparation.
Solvent volumes update from the molecular weight above.
| Mass | 1 mM | 5 mM | 10 mM |
|---|---|---|---|
| 10 mg | 8.8834 mL | 1.7767 mL | 888.34 μL |
| 25 mg | 22.2084 mL | 4.4417 mL | 2.2208 mL |
| 50 mg | 44.4168 mL | 8.8834 mL | 4.4417 mL |
| 100 mg | 88.8336 mL | 17.7667 mL | 8.8834 mL |
| 250 mg | 222.0840 mL | 44.4168 mL | 22.2084 mL |
Contact our team with the catalog number and requested quantity.